Biodegradable hypocrellin derivative nanovesicle as a near-infrared light-driven theranostic for dually photoactive cancer imaging and therapy
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 185, 133-141
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (51572269, 51472252, 61720106014)
- Chinese Academy of Sciences (XDB17000000)
This publication has 53 references indexed in Scilit:
- H2S‐Activable MOF Nanoparticle Photosensitizer for Effective Photodynamic Therapy against Cancer with Controllable Singlet‐Oxygen ReleaseAngewandte Chemie International Edition, 2017
- Ultrastable Near‐Infrared Conjugated‐Polymer Nanoparticles for Dually Photoactive Tumor InhibitionAdvanced Materials, 2017
- Self‐Assembled Peptide‐ and Protein‐Based Nanomaterials for Antitumor Photodynamic and Photothermal TherapyAdvanced Materials, 2017
- Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapyNature Communications, 2016
- Fullerene/photosensitizer nanovesicles as highly efficient and clearable phototheranostics with enhanced tumor accumulation for cancer therapyBiomaterials, 2016
- Albumin Carriers for Cancer Theranostics: A Conventional Platform with New PromiseAdvanced Materials, 2016
- Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and TherapyChemical Reviews, 2016
- Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyaninesNature Nanotechnology, 2014
- Near-infrared light-responsive nanomaterials in cancer therapeuticsChemical Society Reviews, 2014
- Multifunctional nanoparticles for multimodal imaging and theragnosisChemical Society Reviews, 2011